CM662
That’s why Oncosil has targeted bile duct for FDA approval using the HDE (exemption) pathway. Unfortunately, it’s been a long long process. Maybe we will hear back one day?
That’s why Oncosil has sought to make commercial sales in Europe. Although, so far the cash has not been rolling thru the door. That may change if the Company gets GBA Approval for its trial and the cash for device to be used as part of the trial.
We can live in hope!
CM662That’s why Oncosil has targeted bile duct for FDA approval...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.000(0.00%) |
Mkt cap ! $14.43M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 296 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 268 | 1 |
View Market Depth
| Last trade - 10.06am 19/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |
Day chart unavailable